Lewis Gruber

Lewis Gruber

Company: Siwa Therapeutics

Job title: Chief Executive & Scientific Officer


Lewis S. Gruber is the co-founder and CEO of SIWA Therapeutics, Inc. Prior to SIWA, he was interim CEO of a company developing a natural killer cell line product; he resigned to found SIWA. He also co-founded and was CEO of Arryx, Inc. (acquired by a publicly-held company). While CEO, Arryx received awards including World Economic Forum Technology Pioneer (2005) and Red Herring Top 100 Innovator (2004). From 1994 to 2000, he was CEO of Hyseq, Inc. While its CEO, Hyseq completed an IPO (1997 Salomon Inc.). He is the inventor of all SIWA patents and many others.


Case Study: A Triune Approach to Increasing Longevity – SIWA 318H 2:15 pm

Explore what SIWA 318H is Examine SIWA 318H targets How does SIWA 318H increase longevity?Read more

day: Day Two

Panel Discussion: A Therapeutic Revolution Against Aging – Bridging the Gaps & Opportunities 4:50 pm

Examining what we do and do not know about the aging process Exploring the targeting of aging as a disease vs. aging as a common factor for different conditions Analyzing the current R&D landscape for anti-aging therapeutics Discussing recent breakthroughs and the growing interest in this space – attracting funding/ partnerships, important learnings to date…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.